Medications

Second Interim Analysis of Clinical Trial Data Showed a 91.4% Efficacy for the Sputnik V Vaccine on Day 28 After the First Dose; Vaccine Efficacy is Over 95% 42 days After the First Dose

The efficacy of the Sputnik V vaccine is 91.4%, based on the second interim analysis of data obtained 28 days after administering the first dose (7 days after the second dose). Calculation was based on the analysis of data on volunteers (n = 18,794) who received both the first and second doses of the Sputnik […]

Health Problems

Clinical trial to evaluate sepsis treatment in children

Sepsis – a life-threatening inflammatory condition triggered by the body’s massive response to an infection – is diagnosed in about 75,000 children in the U.S. each year and causes about 7,000 deaths. The condition can escalate so rapidly that national guidelines recommend treatment begin within 20 minutes of a patient’s arrival to the emergency department. […]

Health News

Johnson & Johnson pauses coronavirus vaccine trial following ‘unexplained illness’ in participant

Fox News Flash top headlines for October 13 Fox News Flash top headlines are here. Check out what’s clicking on Foxnews.com. Pharmaceutical giant Johnson & Johnson on Monday night announced that it had paused its late-stage COVID-19 vaccine trial after an “unexplained illness” was reported in a participant.  “Adverse events – illnesses, accidents, etc. — even those […]

Health News

How NHS trial is using virtual reality to tackle patient phobias

‘Hi-tech headset finally beat my terror of heights’: How an NHS trial is using virtual reality to tackle patients’ worst phobias New approach of virtual reality therapy run as part of a trial by Oxford University Therapy being rolled out on NHS, including in Oxfordshire and Buckinghamshire  Uses a computer program to create environment that […]

Health News

Clinical trial begins for new COVID-19 treatment

The University of Rochester Medical Center (URMC) is participating in a NIH-sponsored clinical trial to evaluate the safety and efficacy of the investigational antiviral drug remdesivir in hospitalized adults diagnosed with COVID-19. The study is being led by Ann R. Falsey, M.D., and Angela R. Branche, M.D., with the URMC Vaccine Trials and Evaluation Unit […]